Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy (Q45883662)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

0 references

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Daniëlle A M Heideman

1

object named as

Daniëlle A M Heideman

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Chris J L M Meijer

9

object named as

Chris J L M Meijer

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Peter J F Snijders

6

object named as

Peter J F Snijders

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

author name string

Renée M Overmeer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Victor W van Beusechem

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Wouter H Lamers

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Theodorus B M Hakvoort

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Mikael E Craanen

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

G Johan A Offerhaus

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Winald R Gerritsen

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

954-962

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700856

0 references

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

Antiangiogenic gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

21 January 2018

HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Human hepatocyte growth factor stimulates the growth of HuH-6 clone 5 human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700856

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700856

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15905856

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45883662&oldid=2088357358"